Kent Crowley, Pharm.D., is a board-certified Pharm.D. through the American Academy of Anti-Aging Medicine. He received his Doctor of Pharmacy from University of California, San Francisco and completed his residency with Kaiser Permanente in Los Angeles, CA. He completed his ... Fellowship in Metabolic and Nutritional Medicine in 2011. During his 34 years in practice, he has worked in primary research at UCI, Dept. of Pediatrics, Division of Child Development, involved in the development of several drugs; holds two patents in neuropathic pain and a patent on a buccal delivery system incorporating cannabis. Dr. Crowley currently is the Director of R&D at Silver State Trading in Sparks, NV, a 40,000 sq.ft. permitted Clean Green cannabis cultivation and production facility. He serves as the CMO for the Palliative Care Corporation in Huntington Beach, CA, working with patients & physicians incorporating cannabis in disease state treatment and symptoms management, whether as a primary treatment or complementary to traditional and/or other modalities. This same approach is practiced through Bud and Bloom in Santa Ana, CA as a clinic day each week for patients to come to a Best in Class dispensary and get good information/education on cannabis products/dosage forms/routes of administration and incorporate that into a functional medicine consult for personalized treatment goals. Dr. Crowley is a member of the Society of Cannabis Clinicians and serves on the Research Subcommittee and a member of the International Cannabinoid Research Society.

Adam Floyd is the co-founder of Cascade Laboratory Consulting. He holds a Bachelor of Science in Biochemistry and has over ten years of professional experience in the cannabis industry with previous roles at Vermicrop Organics, General Hydroponics, The Hawthorne Gardening ... Company, PerkinElmer, and Think20 Laboratories. He frequently engages in public speaking opportunities in the cannabis laboratory space and is a prolific writer on the subject. Heis also the founder of SoilWorks, a comprehensive plant tissue and soil analysis laboratory. Adam's current research interests include terpenes, gas chromatography, and mass spectrometry.

Michael Key is the founder and CEO of Impello Biosciences, a Colorado-based biotechnology company that specializes in the research and development of plant biostimulants. Their speciality line of biostimulant products currently includes growth-promoting bacteria, amino-acid rich ... organic fertilizers, and unique biochemical compounds that increase secondary metabolite production in cannabis. Michael's role in the company includes overseeing business development, creating strategic partnerships, and directing new product innovation, research, and development. Prior to co-founding Impello, Michael worked as the Director of Horticultural Research and Development for Functional Remedies, a vertically-integrated Colorado hemp company, where he developed and implemented agricultural protocols on 50+ acre farms in both Colorado and Kentucky. Additionally, Michael worked as a Research Assistant in the Center for Rhizosphere Biology at Colorado State University, where he also received his degree in Horticulture.

Dr. Eberhardt Kuhn is the Marketing Manager for Food, Cannabis, and Hemp at Shimadzu Scientific Instruments. He is a renowned chromatographer with over 30 years of experience in this field at companies like Restek, Agilent, and Bio-Rad. Dr. Kuhn has presented talks at ... conferences and events in over 30 countries. His expertise is the field of chromatographic separations, column chemistry, and scientific instrumental analysis of food, including determination and identification of contaminants (pesticides, heavy metals, and Food Contact Materials, such as PFAS), food quality, food adulteration and confirmation of food authenticity, and general analytical method development. His recent interests focus on all aspects of cannabis and hemp analytics, from potency to terpenes to contamination (pesticides, residual solvents, metals), as well as educating the public on the countless benefits of hemp and cannabis.

Catharine is a Scientific Operations, Principal Scientist at Waters Corporation based in Milford, MA. She began her career at a fast paced, biopharmaceutical R&D contract research laboratory where she was responsible for designing analytical methods used for characterization of ... novel biological therapeutics. Catharine spent many years working in large pharma, and later moved into instrument development. At Waters Corporation, she works closely with scientists, engineers, and technical experts throughout the world to innovate, develop, and advance analytical technologies.

Dr. Jahan Marcu has over 15 years of experience in cannabis research, policy, and operations. He has been a passionate advocate focused on consumer safety and the medical benefits of cannabis. He is also among a select group of professionals globally that has earned a PhD ... focused on the endocannabinoid system (with research on the structure and function of cannabinoid receptors, molecular pharmacology of the endocannabinoid system). Furthermore, his efforts include the development of international certification and training programs, co-authoring American Herbal Pharmacopeia's Cannabis Quality Control and Therapeutic Monographs. And he is credited for assisting in the creation of the first nationally adopted standards for the cannabis and hemp industry as the laboratory committee chairman of the cannabis committee for the American Herbal Products Association (AHPA). His dedication to consumer safety is further evident in his work to co-develop a biotech application to predict drug-drug interactions between cannabis and commonly prescribed pharmaceutical drugs. Additionally, Dr. Marcu co-authored one of the first product safety studies on CBD products. Dr. Marcu also provides advising services to government offices in the United States. Dr. Marcu's work has been instrumental to facilitating and supporting fact-based, scientific approaches vital to industry and patients. This has included research focused on solving the structure and function of cannabinoid receptors, the anti-cancer properties of cannabis compounds, as well as method development and validation for analyzing complex formulations. He is also a court-qualified expert witness on cannabis and cannabinoids. Dr. Marcu has published basic and clinical research and is also trained in psilocybin assisted therapy. He is also the founding Editor-In-Chief of the American Journal of Endocannabinoid Medicine. He is Adjunct Faculty at the University of the Sciences in Philadelphia, PA and teaches on the pharmacology of cannabis, regulation and finance for the cannabis industry, and other related subjects for pharmacists, health professionals and business majors. He is also founder and past-chair of the Cannabis Chemistry Sub-division of the American Chemical Society, the world's largest and oldest professional scientific society. Further illustrating the recognition earned through his efforts, he has been asked to serve on multiple expert government advisory and trade association committees, as well as scientific organizations including ASTM (D37 Subcommittee chair), AHPA Cannabis committee (past-chair of laboratory sub-committee), ACS Cannabis Chemistry Subdivision (CANN), AOCS, AOAC, IACM (past BOD), and IMCPC (co-founder). He is also host and producer of the podcast, How to Launch an Industry, which covers scientific and regulatory issues around drug products. Dr. Marcu is a founding partner at the consulting firm of Marcu & Arora, which provides life science consulting to the cannabis and psychedelics fields. Reflecting his dedication to the field, Dr. Marcu has received numerous awards including the Mahmoud Elsohly award for excellence in cannabis chemistry and the Billy Martin research achievement award from the International Cannabinoid Research Society for his work on THC and CBD synergy in aggressive brain cancers. He is also a court-qualified synthetic cannabinoid and cannabis expert. His work has been published and covered in publications such as Rolling Stone, Science, Nature, JAMA, the Washington Post, CNN, and many other media outlets.

Dr. Paszko is the Sr. Vice President at Accelerated Technology Laboratories, Inc. a LIMS, laboratory automation and informatics firm. She is an innovative, customer-centric leader with strong communication skills and the ability to collaborate well with both technical and sales ... teams. She received her undergraduate degree in Medical Technology (MT ASCP), with a minor in Microbiology from the State University of New York @ Buffalo. Her graduate studies were conducted at the University of Maryland in Molecular Microbiology with an emphasis in infectious diseases and informatics. Her unique career combines a Ph.D. with 20+ years of experience in working in laboratories and leveraging data management tools, LIMS and automation. These tools enhance data quality, facilitate regulatory compliance, increase productivity, and the ability better manage laboratory data and information. She has co-authored a book on LIMS, and authored over 5 dozen scientific, LIMS and informatics articles in peer reviewed journals. Dr. Paszko has been helping analytical testing laboratories understand regulatory compliance requirements (ISO 17025), leverage LIMS and automation to increase productivity, throughput and profitability. This approach has helped customers to outperform competitors with best in class Laboratory Information Management Systems Technology, Automation, Systems Integration to offer insights into laboratory and business intelligence.

Martha is a chemist with expertise in diverse areas of analytical chemistry. She had worked as an analyst at a licensed 3rd party analytical laboratory where she focused on developing and validating analytical methods for bioequivalence studies. Later, she had served as a quality ... control expert in the analytical domain and as a monitor in clinical trials. Her interest in the clinical industry led her to be a part of two of the biggest hospitals in Mexico where she gained expertise in hematology, microbiology, and blood banking. Later, she became a member of the team of forensic chemical experts and started working from day one as a specialist in narcotics and drugs. This enabled her to gain rich experience in GC-MS, FTIR, HPLC-MS/MS, ICP-MS, and other analytical techniques for the separation, detection, and quantification of different molecules such as cannabinoids. She had participated in multiple oral trials defending her legal opinions and worked as an expert consultant. She had worked on the synthesis of small molecules for testing them on multi-drug resistant bacteria and mycobacteria, further developing her analytical skills in column chromatography, thin-layer chromatography, microbiology, and compound elucidation by NMR and HRMS. She carried out a research stay at the University of Barcelona with the organic synthesis team. She had also worked on natural products in France and presented her work at conferences in the USA and France. She received awards and accolades for her exceptional work. She has participated in several conferences as a moderator as well. Martha holds a bachelor's degree in Clinical Chemistry from the Faculty of Medicine UANL and a master's degree in Pharmacy from the Faculty of Chemical Sciences UANL, Mexico.

Mr. May brings more than 25 years of cannabis and genomics experience to Endocanna Health. A pioneer in the medical cannabis industry, May has been instrumental in shaping the current legislation and culture. He has held past positions as President of the Cannabis Action Network ... and ​Board Member and Lifetime Member of California Cannabis Association. May is the current chair of the CBDIA science board, and is a ​stakeholder in some of the industry's most iconic brands. His areas of expertise include the workings of the E​ ndocannabinoid system and how genetic expression plays a role in human experiences. A​ s a Certified Medical Cannabis Specialist in Medicinal Genomics, May has an in-depth knowledge of genomics, cannabinoids and terpenes, and their interaction with the endocannabinoid system. As well, he holds a Masters of Medical Cannabis and a certificate in Endocannabinoid Formulation from the Institute for the Advancement of Integrative Medicine. Mr. May is an accomplished public speaker having presented on these topics on some of the world's most prestigious stages in his mission to help educate the population about the healing powers of cannabis. A published author " Making Cannabis Personal" and the host of the popular "Everything is Personal" podcast.

Katherine M. Evans, Ph.D. has over 25 years' experience as an analytical chemist in a variety of industries including toxicology, pharmaceuticals, botanicals/cannabis/hemp with an instrumentation focus of chromatography and mass spectrometry. She holds a Ph.D. from the University ... of Akron in Analytical Chemistry with emphasis on polymer chemistry, with several publications on modeling of Hansen Solubility Parameters and Permeation Data of hand protection (Viton and Nitrile glove materials). She has worked for several instrumentation vendors including Waters Corporation and Thermo Fisher Scientific supporting chromatography methods development and operation, training and application development and support. While at Thermo Fisher she managed the North American Applications Team and participated in the launch of new sample preparation products and provided assistance in marketing and developing application notes for the first solid core particle HPLC column. She has also worked with a team of pharmacists and physicians to develop a generic transdermal pain patch (cGMP), including in-house QC testing & CRO Testing-developed validated methods (HPLC (USP), FT-IR, Dissolution, Stability Testing, Extractables/Leachables Testing, Peel testing, Viscosity) , manufacturing (specialized coating/ heat sealing equipment, dispensing equipment, labeling and packaging), DEA licensing, and FDA-ANDA submission, leading to company purchase by major generic pharmaceutical company -as well as being a transdermal patent holder. She has expertise in toxicology and ran a pain management laboratory on the big island of Hawaii where she setup two laboratories including, drug screening and high complexity testing LCMSMS of pain panels, added robotics, sample cleanup and staff to support growing substance abuse business, she currently holds ASCP Chemical Technologist certification and is licensed as a CLS in Hawaii. The last few years she has participated in committees for standard development including: USP, AOAC, ASTM and NELAC. The hemp/cannabis space is still a very young industry, and she brings significant industry experience which enables her to perform both methods development and methods validation. As a former VP of Lab Operations - Global, Laboratory Director and Technical Supervisor, she has performed both internal and external audits ISO/IEC 17025:2017, CLIA/CAP and most recently participated in the development of D37 ASTM program for certification of testing laboratories in the cannabis/hemp space. This experience has led Dr. Evans to having expansive knowledge in the industry here in the USA as well as Internationally. She is currently owner/CEO of Longboard Scientific Consulting Corporation located in Colorado Springs, Colorado.